EMERALD HEALTH THERAPEUTICS
Emerald Health Therapeutics is a Health Canada Licensed Producer of medical cannabis. A vertically integrated, seed-to-sale enterprise, Emerald has combined core competencies from decades of experience in pharmaceutical innovation with large-scale agriculture expertise. Their ambition is to be at the forefront of developing knowledge and products that provide wellness and health benefits from cannabis.
EMERALD HEALTH THERAPEUTICS
Industry:
Biotechnology Cannabis Medical
Founded:
2007-07-31
Status:
Active
Contact:
1.800.757.3536
Total Funding:
19.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Newstrike Resources
Newstrike Resources is a licensed producer of medical cannabis.
Praxis Precision Medicines
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Steep Hill, Inc
Steep Hill Labs opened the first commercial cannabis lab in the United States in 2007.
Current Employees Featured
Founder
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-05-21 | Prima | Emerald Health Therapeutics investment in Seed Round - Prima | 9.2 M USD |
More informations about "Emerald Health Therapeutics"
Skye Bioscience Closes Acquisition of Emerald Health …
Nov 11, 2022 An early warning report in respect of the Company's acquisition of 213,472,095 Emerald Shares pursuant to the transaction (representing all of the outstanding shares of Emerald) will be filed on SEDAR and will be available …See details»
Emerald Health Therapeutics - Crunchbase
Emerald Health Therapeutics is a Health Canada Licensed Producer of medical cannabis. A vertically integrated, seed-to-sale enterprise, Emerald has combined core competencies from decades of experience in pharmaceutical innovation …See details»
Emerald Health Therapeutics and Skye Bioscience Announce …
Nov 7, 2022 Vancouver, British Columbia--(Newsfile Corp. - November 7, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") and …See details»
Emerald Health Canada (Processing)
On November 10, 2022, Emerald Health Therapeutics, Inc. was acquired by Skye Bioscience, Inc. (OTCQB:SKYE), a San Diego-based pharmaceutical company developing proprietary, …See details»
Skye Bioscience signs arrangement agreement to acquire Emerald …
On May 11, 2022, Skye Bioscience signed a definitive agreement with Emerald Health Therapeutics with respect to a transaction to be completed by way of a Plan of Arrangement …See details»
Emerald Health Therapeutics agrees to sell to Skye Bioscience
On May 12, 2022, Skye Bioscience, Inc. and Emerald Health Therapeutics, Inc. entered a definitive agreement for a Plan of Arrangement, where Skye will acquire all outstanding shares …See details»
Skye Bioscience, Inc. completed the acquisition of Emerald Health ...
Nov 9, 2022 Its Souvenir product is dried flower, which is hang-dried and hand-packaged to optimize terpene profiles. Its Health Therapeutics offers medical products. Its subsidiaries …See details»
Emerald Health Therapeutics Inc Company Profile - Overview
Emerald Health Therapeutics Inc (Emerald Health), formerly T-Bird Pharma Inc, is a producer of pharmaceutical grade medical cannabis. It extracts and markets dried cannabis, and cannabis …See details»
Emerald Health Therapeutics and Skye Bioscience Close Plan of …
Nov 11, 2022 Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") …See details»
Skye Bioscience Reports that Emerald Health Therapeutics …
San Diego, California, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing a proprietary, …See details»
Emerald Health Therapeutics, Inc. Provides Update on and …
Aug 12, 2022 Vancouver, British Columbia--(Newsfile Corp. - August 12, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") is providing …See details»
Emerald Health Therapeutics Pivots Out of Recreational and …
Nov 29, 2023 Vancouver, British Columbia--(Newsfile Corp. - November 29, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald" or the "Company") today …See details»
Emerald Health Therapeutics - LPC Marketplace - Licensed …
Apr 7, 2024 Emerald Health Therapeutic Canada Inc. is an authorized licensed cultivator, processor and seller under the Cannabis Act. A vertically integrated, seed-to-sale enterprise, …See details»
Emerald Health Therapeutics, Inc. - Canadian Securities Exchange
Apr 27, 2021 Emerald Health Therapeutics, Inc. Listing Date. April 27, 2021. Website. emeraldhealth.ca. Social. Emerald is a cannabis company that is committed to creating new …See details»
Emerald Health Therapeutics Company Profile - Office Locations
Emerald Health Therapeutics $9.68 m in annual revenue in FY 2021. See insights on Emerald Health Therapeutics including office locations, competitors, revenue, financials, executives, …See details»
Emerald Health Therapeutics, Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Emerald Health Therapeutics, Inc of Victoria, BC. Get the latest business insights from Dun & Bradstreet.See details»
Skye Bioscience Closes Acquisition of Emerald Health Therapeutics
Nov 11, 2022 The common shares of Emerald ("Emerald Shares") held by broker dealers will be automatically exchanged for 1.95 shares of Skye, as per the plan of arrangement agreed to …See details»
Emerald exiting Canada’s cannabis industry after losing over …
Dec 2, 2021 Emerald Health Therapeutics plans to exit Canada’s recreational and medical cannabis sectors after racking up more than 200 million Canadian dollars ($156 million) in …See details»
Emerald Health Sells Quebec Subsidiaries For $21.0 Million In Cash
Jul 31, 2020 Emerald Health Therapeutics last traded at $0.19 on the TSX Venture. Information for this briefing was found via Sedar and Emerald Health Therapeutics. The author has no …See details»
Emerald Health Therapeutics Signs Arrangement Agreement with …
May 12, 2022 Arrangement is expected to fund Skye's proprietary synthetic cannabinoid-derivative therapeutic initially targeting glaucoma for first Phase 2 clinical study planned to …See details»